SAC's Cohen trying to unload stake in Kadmon Pharmaceuticals

Reuters

BOSTON (Reuters) - SAC Capital Advisors' founder Steven A. Cohen is trying to sell his stake in privately held Kadmon Pharmaceuticals, a person familiar with the matter said on Thursday.

Kadmon was founded by Sam Waksal, who served a five year prison term for insider stock trading. Cohen invested $30 million (18.5 million pounds) in the company.

A spokesman for Kadmon declined to comment. A spokesman for Cohen declined to comment.

(Reporting by Svea Herbst-Bayliss, editing by Richard Valdmanis)

View Comments (0)

Recommended for You